(Q44011623)

English

Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease

scientific article published in March 2002

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Youdim MB

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Tipton KF

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Parkinsonism and Related Disorders

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

247-253

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Rescue of axotomized immature rat facial motoneurons by R(-)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Turnover of brain monoamine oxidase measured in vivo by positron emission tomography using L-[11C]deprenyl

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo release of endogenous dopamine, 5-hydroxytryptamine and some of their metabolites from rat caudate nucleus by phenylethylamine

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase B

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Slow recovery of human brain MAO B after L-deprenyl (Selegeline) withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific [3H] beta-phenylethylamine binding sites in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective acetylenic 'suicide' and reversible inhibitors of monoamine oxidase types A and B

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical neuromythology IX. Pyramid sale in the bucket shop: DATATOP bottoms out

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism underlying anti-apoptotic activity of a (-)deprenyl-related propargylamine, rasagiline.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Selegiline as initial treatment in de novo parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of deprenyl on the progression of disability in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

2-Phenylethylamine: a modulator of catecholamine transmission in the mammalian central nervous system?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Possible mechanism of action of deprenyl in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo release of endogenous dopamine from rat caudate nucleus by phenylethylamine

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Deprenyl reduces the death of motoneurons caused by axotomy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

(R)(+)-N-propargyl-1-aminoindan (rasagiline) and derivatives: highly selective and potent inhibitors of monoamine oxidase B.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The oxidation of tryptamine by the two forms of monoamine oxidase in human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

(-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of deprenyl (selegiline) on the natural history of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinct monoamine oxidase A and B populations in primate brain

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1353-8020(01)00011-6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44011623&oldid=2105621504"